A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP
NCT06362759
C-reactive Protein, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT00819273
An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Research Site, Wŏnju, Gangwon-do, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within the last 12 months from the date of data entry.
Time frame: Within the last 12 months from the date of data entry.
AstraZeneca
Industry
Acronym: CALLISTO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06362759
C-reactive Protein, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT05130892
NLRP3, Percutaneous Coronary Intervention
Wuhan, Hubei, China
View Trial DetailsNCT06997770
hsCRP
Rohtak, Haryana, India
View Trial DetailsNCT05131750
hsCRP
Wuhan, Hubei, China
View Trial Details